Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Promising clinical results with MS vaccine

Oct. 18, 1996

Berlex suit relating to Avonex dismissed

Oct. 18, 1996

GV-4000 available for licensing

Oct. 18, 1996

Potential new class of neuroleptics discovered at NYU

Oct. 18, 1996

Antipsychotic agents from Asahi Chem.

Oct. 18, 1996

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Barr re-introduces generic drug for pain

Oct. 18, 1996

Tentative FDA approval for generic analgesic

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Yamanouchi's CNS products in the pipeline

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...